About China Meheco Group Company

The company is a listed company controlled by General Technology Group. Its predecessor was the China National Pharmaceutical and Health Products Import and Export Corporation established in 1983. It joined General Technology Group in 1999 and has now become the only pharmaceutical and medical device manufacturing and operation platform under the Group. At present, Chinese medicine has built an integrated industrial pattern of trade, industry, technical services, etc. with the pharmaceutical and medical device business as the engine and the pharmaceutical industry as the support. The industrial form involves the entire industrial chain of planting and processing, R&D, production, sales, logistics, import and export trade, academic promotion, and technical services. The company's main business is pharmaceutical industry business, pharmaceutical commercial business, and medical device business. The company's main products are Chinese herbal medicines, Chinese medicine tablets, traditional Chinese medicine extracts, proprietary Chinese medicine and health products, etc., chemical preparations, chemical raw materials, diagnostic drugs and reagents, medical consumables, medical devices, specialty medical products, traditional Chinese herbal medicines and tablets, formula granules, biological agents, nutritional health products, etc., medical and rehabilitation equipment, consumables, IVD, etc., and has all categories of medical devices such as implantation consumables, general consumables, diagnostic reagents, large-scale medical equipment, and chemical dangerous goods. Corporate honors: In 2018, China Pharmaceutical won the “Listed Company China Innovative Enterprise Award”, “Listed Company with Outstanding Contribution to the 40th Anniversary of China's Reform and Opening-up”, “China's Most Valuable Listed Company Award”, “China's Top 100 Listed Companies Award”, “Listed Company Most Respected by Investors”, “Golden Junma Award for Listed Companies with the Most Craftsmanship”, “Listed Company 2018 Charity Action Award for Listed Companies”, and “2024 Chinese Healthcare Industry Green and Sustainable Practitioner”.